Loading
Life sciences · Journal article
European Journal of Psychotraumatology · September 21, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Although posttraumatic stress disorder (PTSD) and pain commonly co-occur, interventions often target them separately. No studies have compared the impact of PTSD psychotherapy, pharmacotherapy, and their combination on pain.Objectives: This secondary analysis of a PTSD effectiveness trial examined the impact of PTSD treatments on pain complaints in 196 veterans randomized to three conditions: Prolonged Exposure plus placebo (PE + PLB), PE + Sertraline (PE + SERT), and SERT with enhanced medication management, overall and among those who reported clinically significant pain at baseline.Method: Linear mixed models assessed change on the Brief Pain Inventory (Pain Severity and Interference subscales) over 52 weeks across treatments in the overall sample, and in those with clinically significant baseline pain interference (≥ 5, n = 70) and baseline pain severity (≥ 5, n = 93).Results: Veterans overall, and those with clinically significant baseline pain interference and severity, showed significant reductions in pain interference and severity scores across time in all treatments. The PE + PLB group showed greater reductions in pain interference during treatment than SERT and PE + SERT. Veterans with clinically significant baseline pain severity showed significant reduction in pain severity across time in all treatments, with no evidence for differential rates across treatments.Conclusion: While it is uncertain reduced pain was due to the treatments themselves, lower scores for all treatments suggest that PTSD-focused treatments may reduce pain even without a specific pain focus. Research is needed to isolate, if present, mechanistic pathways between PTSD treatment and pain reduction.Trial registration: ClinicalTrials.gov identifier: NCT01524133.